'Novo and Hims End Feud, Will Sell Obesity Drugs Together' - Bloomberg News

Novo Nordisk and Hims & Hers Health have resolved their previous disputes and will collaborate to market obesity drugs. This partnership aims to leverage both companies' strengths in the healthcare sector to enhance their market presence. The strategic alliance is expected to impact their sales positively, although specific financial projections were not disclosed.